The administration of the synthetic peptide YMESRADR with a low aspirin dose significantly augments its antiplatelet effect, in contrast to the highly constrained peptide (S,S) PSRCDCR-NH2. An experimental study
| Autor: | Englezopoulos, K.V., Stathopoulou, E.M., Moussis, V., Chantzichristos, V.G., Papamichael, N.D., Tatsidou, P.T., Roussa, V.D., Tsoumani, M.E., Lakkas, L., Rammos, A., Katsouras, C.S., Fotou, E., Tsikaris, V., Tselepis, A.D., Michalis, L.K. |
|---|---|
| Zdroj: | In Hellenic Journal of Cardiology May-June 2022 65:56-58 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|